CME Group Inc.
CME- Exchange
- Nasdaq
- Industry
- Security & Commodity Brokers, Dealers, Exchanges & Services
- SEC CIK
- 0001156375
In the last 90 days, CME Group Inc. insiders filed 1 open-market purchase and 7 sales; 1,718 institutions reported holding it in 13F filings for Q2 2026, worth $71.2B in total; 5 superinvestors hold it, including Baupost Group and Viking Global Investors.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 24, 2026, 1:07 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 4, 2026 | Feb 12, 2025 | Feb 14, 2024 | Feb 8, 2023 | Feb 9, 2022 |
| Revenue | $6.52B | $6.13B | $5.58B | $5.02B | $4.69B |
| Operating income | $4.23B | $3.93B | $3.44B | $3.02B | $2.65B |
| Income tax | $1.26B | $1.02B | $927.4M | $799.3M | $736.7M |
| Net income | $4.07B | $3.53B | $3.23B | $2.69B | $2.64B |
| EPS, basic | $11.18 | $9.69 | $8.87 | $7.41 | $7.30 |
| EPS, diluted | $11.16 | $9.67 | $8.86 | $7.40 | $7.29 |
| Weighted shares, basic | 359.6M | 359.4M | 359.0M | 358.7M | 358.3M |
| Weighted shares, diluted | 360.3M | 359.9M | 359.5M | 359.2M | 358.9M |
| Margins and growth | |||||
| Operating margin | 64.9% | 64.1% | 61.6% | 60.1% | 56.4% |
| Net margin | 62.5% | 57.5% | 57.8% | 53.6% | 56.2% |
| Revenue growth, year over year | +6.4% | +9.9% | +11.1% | +7.0% | −4.0% |
| Net income growth, year over year | +15.5% | +9.3% | +19.9% | +2.1% | +25.2% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 4, 2026 | Feb 12, 2025 | Feb 14, 2024 | Feb 8, 2023 | Feb 9, 2022 |
| Cash and equivalents | $4.42B | $2.89B | $2.91B | $2.72B | $2.83B |
| Short-term investments | $125.0M | $113.2M | $111.7M | $96.0M | $115.0M |
| Accounts receivable | $639.2M | $573.1M | $535.6M | $483.2M | $434.5M |
| Total current assets | $165.4B | $103.0B | $94.9B | $139.1B | $161.8B |
| Property, plant and equipment | $362.7M | $386.2M | $409.5M | $455.5M | $505.3M |
| Goodwill | $10.5B | $10.5B | $10.5B | $10.5B | $10.5B |
| Intangible assets | $2.61B | $2.82B | $3.05B | $3.27B | $3.53B |
| Total assets | $198.4B | $137.4B | $129.7B | $174.2B | $196.8B |
| Accounts payable | $71.8M | $79.9M | $90.6M | $121.4M | $48.8M |
| Short-term debt | $0 | $749.8M | $0 | $16.0M | $749.4M |
| Total current liabilities | $160.3B | $102.3B | $93.4B | $137.7B | $160.4B |
| Total liabilities | $169.7B | $111.0B | $103.0B | $147.3B | $169.4B |
| Shareholders' equity | $28.7B | $26.5B | $26.7B | $26.9B | $27.4B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 4, 2026 | Feb 12, 2025 | Feb 14, 2024 | Feb 8, 2023 | Feb 9, 2022 |
| Operating cash flow | $4.28B | $3.69B | $3.45B | $3.06B | $2.40B |
| Capital expenditures | $83.5M | $94.0M | $76.4M | $89.7M | $127.2M |
| Free cash flow | $4.19B | $3.60B | $3.38B | $2.97B | $2.28B |
| Depreciation and amortization | $107.5M | $115.1M | $126.0M | $134.9M | $147.8M |
| Stock-based compensation | $94.8M | $89.5M | $82.9M | $84.3M | $75.2M |
| Dividends paid | $3.93B | $3.58B | $3.24B | $2.63B | $2.19B |
| Investing cash flow | $1.50B | -$82.6M | $20.9M | -$489.8M | $58.4M |
| Financing cash flow | $56.5B | $5.08B | -$48.3B | -$25.4B | $69.9B |
| Net change in cash | $62.3B | $8.68B | -$44.9B | -$22.8B | $72.4B |
| Ratio | |||||
| Stock-based compensation, % of revenue | 1.5% | 1.5% | 1.5% | 1.7% | 1.6% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.